[1]Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012 [J]. CA Cancer J Clin, 2012,62(1):10-29.
[2]Lin Y, Ueda J, Kikuchi S, et al. Comparative epidemiology of gastric cancer between Japan and China [J]. World J Gastroenterol, 2011,17(39), 4421-4428.
[3]Sturgeon CM, Duffy MJ, Hofmann BR, et al. National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers [serial online] [J]. Clin Chem, 2010,56(6):e1-e48.
[4]Yamamoto H, Kohashi K, Fujita A, et al. Fascin-1 overexpression and miR-133b downregulation in the progression of gastrointestinal stromaltumor [J]. Mod Pathol,2013,26(4):563-571.
[5]Xu XC, Zhang YH, Zhang WB, et al. MicroRNA-133a functions as a tumor suppressor in gastric cancer [J]. J Biol Regul Homeost Agents, 2014,28(4):615-624.
[6]Wu WK, Lee CW, Cho CH, et al. MicroRNA dysregulation in gastric cancer: a new player enters the game [J]. Oncogene, 2010,29(43), 5761-5771.
[7]Qiu T, Zhou X, Wang J, et al. MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer [J]. FEBS Lett, 2014,588(7):1168-1177.
[8]Zhou Y, Wu D, Tao J, et al. MicroRNA-133 inhibits cell proliferation, migration and invasion by targeting epidermal growth factor receptor and its downstream effector proteins in bladder cancer [J]. Scandinavian J Urol, 2013, 47(5): 423-432.
[9]Tucci A, Bisceglia M, Rugge M, et al. Clinical usefulness of gastric-juice analysis in 2007: the stone that the builders rejected has become the cornerstone [J]. Gastrointest Endosc, 2007,66(5): 881-890.
[10]Yamasaki T, Yoshino H, Enokida H, et al. Novel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancer [J]. Int J Oncol, 2012, 40(6): 1821-1830.
[11]Zhang X, Cui L, Ye G, et al. Gastric juice microRNA-421 is a new biomarker for screening gastric cancer [J]. Tumour Biol, 2012,33(6): 2349-2355.
[12]Kinoshita T, Hanazawa T, Nohata N, et al. Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma [J]. Oncotarget, 2012, 3(11): 1386-1400.
[13]Park NJ, Zhou H, Elashoff D, et al. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection [J]. Clin Cancer Res, 2009,15(17):5473-5477.
[14]Chen X, Liang H, Zhang J, et al. Horizontal transfer of microRNAs: molecular mechanisms and clinical applications [J]. Protein Cell, 2012,3(1):28-37.
[15]Ohshima K, Inoue K, Fujiwara A, et al. Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line [serial online] [J]. PLoS One, 2010,5(10):e13247.
[16]Qiu T, Zhou X, Wang J, et al. MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer [J]. FEBS Lett, 2014, 588(7): 1168-1177.
[17]Gong Y, Ren J, Liu K, et al. Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1R [J]. World J Gastroenterol, 2015, 21(10): 2949-2958.
[18]Chen WS, Leung CM, Pan HW, et al. Silencing of miR-1-1 and miR-133a-2 cluster expression by DNA hypermethylation in colorectal cancer [J]. Oncol Rep, 2012, 28(3):1069-1076.
[19]Tucci A, Bisceglia M, Rugge M, et al. Clinical usefulness of gastric-juice analysis in 2007: the stone that the builders rejected has become the cornerstone [J]. Gastrointest Endosc, 2007, 66(5):881-890.
[20]Shao J, Fang PH, He B, et al. Downregulated MicroRNA-133a in gastric juice as a clinicopathological biomarker for gastric cancer screening [J]. Asian Pac J Cancer Prev, 2016,17(5):2719-2722.
|